64
|
255
|
7e60A |
The crystal structure of peptidoglycan peptidase in complex with inhibitor 1 |
63
|
255
|
7e69A |
The crystal structure of peptidoglycan peptidase in complex with inhibitor 3-3 |
230
|
676
|
7u6bB |
Crystal structure of danio rerio histone deacetylase 10 in complex with indolethyl piperidine-4-acrylhydroxamic acid inhibitor |
230
|
676
|
7u69A |
Crystal structure of danio rerio histone deacetylase 10 in complex with phenethyl piperidine-4-acrylhydroxamic acid inhibitor |
258
|
778
|
7t8vA |
Co-crystal structure of chaetomium glucosidase i with eb-0159 |
226
|
676
|
7u6aA |
Crystal structure of danio rerio histone deacetylase 10 in complex with 3-thienylmethyl benzhydroxamic acid inhibitor |
257
|
778
|
7t66A |
Co-crystal structure of chaetomium glucosidase with compound uv-4 |
263
|
778
|
7t68A |
Co-crystal structure of chaetomium glucosidase with compound uv-5 |
80
|
245
|
7rpeA |
X-ray crystal structure of oxa-24/40 in complex with ertapenem |
80
|
245
|
7rpfA |
X-ray crystal structure of oxa-24/40 in complex with doripenem |
84
|
244
|
7rpdA |
X-ray crystal structure of oxa-24/40 v130d in complex with ertapenem |
82
|
244
|
7rpcA |
X-ray crystal structure of oxa-24/40 k84d in complex with ertapenem |
80
|
245
|
7rpgA |
X-ray crystal structure of oxa-24/40 k84d in complex with cefotaxime |
79
|
245
|
7rpaA |
X-ray crystal structure of oxa-24/40 k84d in complex with meropenem |
265
|
778
|
7r6jA |
Co-crystal structure of chaetomium glucosidase with compound 1 |
81
|
244
|
7rpbA |
X-ray crystal structure of oxa-24/40 v130d in complex with meropenem |
82
|
244
|
7rp9A |
X-ray crystal structure of oxa-24/40 v130d in complex with imipenem |
78
|
244
|
7rp8A |
X-ray crystal structure of oxa-24/40 k84d in complex with imipenem |
121
|
323
|
7farA |
Crystal structure of pde5a in complex with inhibitor l12 |
106
|
287
|
7mhdA |
Thioesterase domain of human fatty acid synthase (fasn-te) binding a competitive inhibitor sbp-7635 |
234
|
804
|
7mfhA |
Crystal structure of bio-32546 bound mouse autotaxin |
101
|
284
|
7mheAAA |
Thioesterase domain of human fatty acid synthase (fasn-te) binding a competitive inhibitor sbp-7957 |
127
|
427
|
7n18A |
Clostridium botulinum neurotoxin serotype a light chain inhibited by a chiral hydroxamic acid |
123
|
323
|
7faqA |
Crystal structure of pde5a in complex with inhibitor l1 |
125
|
316
|
7f0iA |
Phosphodiesterase-9a in complex with inhibitor 4b |
33
|
115
|
8ev5A |
Nlpc b3 covalently bound with e64 inhibitor fragment |
108
|
344
|
8d4zA |
Crystal structure of usp7 in complex with allosteric inhibitor fx1-3763 |
127
|
317
|
8e5mA |
Structure of arg1 complex with pyrrolidine-based non-boronic acid inhibitor 6 |
14
|
76
|
8jygB |
Crystal structure of human hpse1 in complex with inhibitor |
136
|
466
|
8t1rA |
Crystal structure of human cpsf73 catalytic segment in complex with compound 2 |
83
|
265
|
8gctA |
Xfel structure of mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for 6 ms |
83
|
265
|
8gcsA |
Xfel structure of mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for 3 ms |
114
|
360
|
8sknA |
Crystal structure of compound 3-bound human dynamin-1-like protein gtpase-bse fusion |
74
|
230
|
8skpA |
X-ray structure of the ndm-4 beta-lactamase from klebsiella pneumonia in complex with 1-hydroxypyridine-2(1h)-thione-6-carboxylic acid |
75
|
230
|
8skoA |
X-ray structure of the ndm-4 beta-lactamase from klebsiella pneumonia with l-captopril bound |
88
|
265
|
8gcvA |
Xfel structure of mycobacterium tuberculosis beta lactamase microcrystals |
82
|
265
|
8gcxA |
Xfel structure of mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for 700 ms |
140
|
466
|
8t1qA |
Crystal structure of human cpsf73 catalytic segment in complex with compound 1 |
116
|
384
|
8jygA |
Crystal structure of human hpse1 in complex with inhibitor |
136
|
356
|
8tq0A |
Crystal structure of danio rerio histone deacetylase 6 catalytic domain 2 complexed with (r)-lipoic acid |
162
|
523
|
8t8qA |
Identification of gdc-1971 (rly-1971), a shp2 inhibitor designed for the treatment of solid tumors |
92
|
244
|
8fajA |
Oxa-48-na-1-157 inhibitor complex |
99
|
263
|
7fqkA |
Crystal structure of human legumain in complex with (2s)-n-[(3s)-5-amino-1-(1,3-oxazol-2-yl)-5-oxopent-1-yn-3-yl]-1-[1-[4-(trifluoromethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide |
99
|
262
|
7fqhA |
Crystal structure of human legumain in complex with (2s)-n-[(3s)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide |
99
|
265
|
7fqjA |
Crystal structure of human legumain in complex with (2s)-n-[(1s)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide |
99
|
265
|
7fqiA |
Crystal structure of human legumain in complex with (2s)-n-[(1s)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide |
61
|
203
|
8dlaA |
Clpp2 from chlamydia trachomatis bound by mas1-12 |
93
|
263
|
8g2tA |
Crystal structure of the kpc-2 d179n variant in complex with relebactam (imine hydrolysis intermediate) |
113
|
299
|
8sklA |
Ptp1b in complex with 182 |
208
|
714
|
8hayA |
D4-bound btdpp4 |